Wave Life Sciences Ltd. Contracts & Agreements
86 Contracts & Agreements
- Business Finance (35 contracts)
- Business Operations (2)
- Human Resources (32)
- Intellectual Property (3)
- Real Estate (8)
- Uncategorized (6)
- Form of Pre-Funded Warrant (Filed With SEC on September 26, 2024)
- Underwriting Agreement, dated September 25, 2024, by and between the Company and J.P. Morgan Securities LLC and Leerink Partners LLC (Filed With SEC on September 26, 2024)
- Wave Life Sciences Ltd. 2021 Equity Incentive Plan, as amended (Filed With SEC on August 12, 2024)
- Form of Inducement Non-qualified Share Option Agreement (Filed With SEC on August 8, 2024)
- Form of Inducement Restricted Share Unit Agreement (Filed With SEC on August 8, 2024)
- Description of Securities of the Registrant and Comparison of Shareholder Rights (Filed With SEC on March 6, 2024)
- Underwriting Agreement, dated December 6, 2023, by and between the Company and J.P. Morgan Securities LLC and Leerink Partners LLC (Filed With SEC on December 8, 2023)
- Non-Employee Director Compensation Policy, effective as of August 7, 2023 (Filed With SEC on November 9, 2023)
- Wave Life Sciences Ltd. 2021 Equity Incentive Plan, as amended (Filed With SEC on August 7, 2023)
- Wave Life Sciences Ltd. 2019 Employee Share Purchase Plan, as amended (Filed With SEC on August 7, 2023)
- Description of Securities of the Registrant and Comparison of Shareholder Rights (Filed With SEC on August 3, 2023)
- Non-Employee Director Compensation Policy, effective as of August 15, 2022 (Filed With SEC on November 10, 2022)
- Wave Life Sciences Ltd. 2021 Equity Incentive Plan, as amended (Filed With SEC on August 15, 2022)
- Second Amendment (to Lease) by and between Wave Life Sciences USA, Inc. and CPI/King 733 Concord Owner, LLC, dated as of August 8, 2022 (Filed With SEC on August 11, 2022)
- Form of Pre-Funded Warrant (Filed With SEC on June 14, 2022)
- Underwriting Agreement, dated June 14, 2022, by and between the Company and SVB Securities LLC (Filed With SEC on June 14, 2022)
- First Amendment to Collaboration and License Agreement by and between Wave Life Sciences USA, Inc., Wave Life Sciences UK Limited and Takeda Pharmaceutical Company Limited, dated... (Filed With SEC on May 12, 2022)
- Description of Securities of the Registrant and Comparison of Shareholder Rights (Filed With SEC on May 12, 2022)
- Amendment No. 2, dated March 3, 2022, to the Open Market Sale Agreement, dated as of May 10, 2019, by and between Wave Life Sciences Ltd. and Jefferies LLC (Filed With SEC on March 3, 2022)
- Second Amendment to Collaboration and License Agreement by and between Wave Life Sciences USA, Inc., Wave Life Sciences UK Limited and Takeda Pharmaceutical Company Limited, dated... (Filed With SEC on March 3, 2022)
- Description of Securities of the Registrant and Comparison of Shareholder Rights (Filed With SEC on March 3, 2022)
- Form of Non-qualified Share Option Agreement for UK Participants under the 2021 Equity Plan, effective as of August 10, 2021 (Filed With SEC on November 10, 2021)
- Form of Inducement Restricted Share Unit Agreement (Filed With SEC on November 10, 2021)
- Form of Restricted Share Unit Agreement for UK Participants under the 2021 Equity Plan, effective as of August 10, 2021 (Filed With SEC on November 10, 2021)
- Form of Restricted Share Unit Agreement under the 2021 Equity Plan, effective as of August 10, 2021 (Filed With SEC on November 10, 2021)
- Form of Non-qualified Share Option Agreement under the 2021 Equity Plan, effective as August 10, 2021 (Filed With SEC on November 10, 2021)
- Wave Life Sciences Ltd. 2021 Equity Incentive Plan (the 2021 Equity Plan) (Filed With SEC on November 10, 2021)
- Non-Employee Director Compensation Policy, effective as of August 16, 2021 (Filed With SEC on November 10, 2021)
- Form of 2021 Performance-Based Restricted Share Unit Agreement under the 2014 Equity Incentive Plan, effective as of March 17, 2021 (Filed With SEC on May 13, 2021)
- Form of Amended and Restated 2019 Performance-Based Restricted Share Unit Agreement under the 2014 Equity Incentive Plan, effective as of March 17, 2021 (Filed With SEC on May 13, 2021)
- Employment Agreement, as amended and restated, between the Registrant and Kyle Moran, dated as of January 1, 2021 (Filed With SEC on March 4, 2021)
- Description of Securities of the Registrant and Comparison of Shareholder Rights (Filed With SEC on March 4, 2021)
- First Amendment (to Lease) by and between Wave Life Sciences USA, Inc. and CPI/King 733 Concord Owner, LLC, dated as of December 9, 2020 (Filed With SEC on March 4, 2021)
- Non-Employee Director Compensation Policy, effective as of August 18, 2020 (Filed With SEC on November 9, 2020)
- Underwriting Agreement, dated September 22, 2020, by and among the Company, Jefferies LLC, SVB Leerink LLC and Mizuho Securities USA LLC (Filed With SEC on September 23, 2020)
- Form of Inducement Non-qualified Share Option Agreement (Filed With SEC on August 10, 2020)
- Employment Agreement, as amended and restated, between the Registrant and Paul B. Bolno, dated as of May 8, 2020 (Filed With SEC on August 10, 2020)
- Employment Agreement, as amended and restated, between the Registrant and Chandra Vargeese, dated as of May 8, 2020 (Filed With SEC on August 10, 2020)
- Description of Securities of the Registrant (Filed With SEC on March 2, 2020)
- Employment Agreement between the Registrant and Mark Baldry, dated as of June 28, 2019 (Filed With SEC on November 5, 2019)
- Non-Employee Director Compensation Policy, effective as of August 15, 2019 (Filed With SEC on November 5, 2019)
- Wave Life Sciences Ltd. 2019 Employee Share Purchase Plan, effective as of August 15, 2019 (Filed With SEC on November 5, 2019)
- Form of Performance-Based Restricted Share Unit Agreement under the Wave Life Sciences Ltd. 2014 Equity Incentive Plan, as amended, effective as of March 7, 2019 (Filed With SEC on May 10, 2019)
- Form of Restricted Share Unit Agreement under the Wave Life Sciences Ltd. 2014 Equity Incentive Plan, as amended, effective as of January 1, 2019 (Filed With SEC on May 10, 2019)
- Form of Restricted Share Unit Agreement under the 2014 Equity Plan, effective as of January 1, 2018 (Filed With SEC on March 1, 2019)
- Form of Non-qualified Share Option Agreement under the 2014 Equity Plan, effective as of January 1, 2018 (Filed With SEC on March 1, 2019)
- Form of Non-qualified Share Option Agreement for UK Participants under the 2014 Equity Plan, effective as of January 1, 2018 (Filed With SEC on March 1, 2019)
- Underwriting Agreement, dated January 24, 2019, by and among the Company, Jefferies LLC, SVB Leerink LLC and Mizuho Securities USA LLC (Filed With SEC on January 24, 2019)
- Non-Employee Director Compensation Policy, as amended, effective as of August 13, 2018 (Filed With SEC on November 9, 2018)
- Amendment No. 1 to Investors Rights Agreement by and among the Registrant and certain of its shareholders, dated as of November 8, 2018 (Filed With SEC on November 9, 2018)
- Amendment No. 1 to Research, License and Option Agreement by and between the Registrant and Pfizer Inc., dated as of November 5, 2017 (Filed With SEC on March 12, 2018)
- Form of Non-qualified Share Option Agreement for UK Participants under the 2014 Equity Incentive Plan, as amended (Filed With SEC on November 9, 2017)
- Form of Restricted Share Unit Agreement under the 2014 Equity Incentive Plan, as amended (Filed With SEC on November 9, 2017)
- Form of Incentive Share Option Agreement under the 2014 Equity Incentive Plan, as amended (Filed With SEC on November 9, 2017)
- Form of Non-qualified Share Option Agreement under the 2014 Equity Incentive Plan, as amended (Filed With SEC on November 9, 2017)
- Wave Life Sciences Ltd. 2014 Equity Incentive Plan, as amended (Filed With SEC on November 9, 2017)
- 4,166,667 Ordinary Shares WAVE Life Sciences Ltd. UNDERWRITING AGREEMENT (Filed With SEC on April 12, 2017)
- 115 HARTWELL AVENUE Lexington,Massachusetts 02421 (the Building) FIRST AMENDMENT (Filed With SEC on January 6, 2017)
- WAVE LIFE SCIENCES LTD. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (Filed With SEC on November 10, 2016)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on November 9, 2016)
- WAVE LIFE SCIENCES LTD. 2014 EQUITY INCENTIVE PLAN Incentive Share Option Agreement (Filed With SEC on November 9, 2016)
- WAVE LIFE SCIENCES LTD. 2014 EQUITY INCENTIVE PLAN Non-qualified Share Option Agreement (Filed With SEC on November 9, 2016)
- Wave Life Sciences Ltd. 2014 EQUITY INCENTIVE PLAN Restricted Share Unit Agreement (Filed With SEC on November 9, 2016)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on November 9, 2016)
- 115 HARTWELL AVENUE LEXINGTON,MASSACHUSETTS 02421 LEASE SUMMARY SHEET (Filed With SEC on September 27, 2016)
- RESEARCH, LICENSE AND OPTION AGREEMENT (Filed With SEC on August 15, 2016)
- SHARE PURCHASE AGREEMENT (Filed With SEC on August 15, 2016)
- SCHEDULE 1 The Financial Contribution (Filed With SEC on November 6, 2015)
- SCHEDULE 1 The Financial Contribution (Filed With SEC on November 6, 2015)
- [] Ordinary Shares WAVE Life Sciences Ltd. UNDERWRITING AGREEMENT (Filed With SEC on November 2, 2015)
- WAVE LIFE SCIENCES PTE. LTD. 2014 EQUITY INCENTIVE PLAN (Filed With SEC on November 2, 2015)
- WAVE LIFE SCIENCES PTE. LTD. 2014 EQUITY INCENTIVE PLAN (Filed With SEC on October 9, 2015)
- WAVE LIFE SCIENCES PTE. LTD. INVESTORS RIGHTS AGREEMENT TABLE OF CONTENTS (Filed With SEC on October 9, 2015)
- Amendment 1 to the Commercial Lease Agreement (Filed With SEC on October 9, 2015)
- Harvard Real Estate Services Holyoke Center, Suite 800 Cambridge, Massachusetts 02138-3826 LEASE Between HARVARD REAL ESTATE ALLSTON, INC. as Landlord and SNBL USA, LTD. as Tenant... (Filed With SEC on October 9, 2015)
- CONSENT TO OFFICE SPACE SUBLEASE 1320 SOLDIERS FIELD ROAD, BOSTON, MASSACHUSETTS (Filed With SEC on October 9, 2015)
- Commercial Lease Agreement (Filed With SEC on October 9, 2015)
- SCHEDULE 1 The Financial Contribution (Filed With SEC on October 9, 2015)
- ONTORII, INC. CONSULTING AGREEMENT (Filed With SEC on October 9, 2015)
- EMPLOYMENT AGREEMENT (Filed With SEC on October 9, 2015)
- - 2 - (Filed With SEC on October 9, 2015)
- DEED OF INDEMNITY (Filed With SEC on October 9, 2015)
- CONFIDENTIAL CO-EXCLUSIVE LICENSE AGREEMENT between Max-Planck-InnovationGmbH a German corporation having a principal place of business at Amalienstr. 33, 80799 Muenchen, Germany... (Filed With SEC on October 9, 2015)
- SCHEDULE 1 The Financial Contribution (Filed With SEC on October 9, 2015)
- MASTER SPONSORED RESEARCH AGREEMENT (Filed With SEC on October 9, 2015)
- 733 CONCORD AVENUE CAMBRIDGE,MASSACHUSETTS LEASE SUMMARY SHEET (Filed With SEC on October 9, 2015)
